Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
European Archives of Psychiatry and Clinical Neuroscience|January 1, 1996
Effects of chronic treatment with methadone and naltrexone on sleep in addictsJ Staedt, F Wassmuth, G Stoppe, et al.
Der Nervenarzt|August 1, 1996
[Ambulatory, comprehensive, behavior therapy-oriented weight reduction program (Optifast Program). An alternative therapy in obstructive sleep apnea]G Herrendorf, G Hajak, A Rodenbeck, et al.
Psychopharmacology|January 1, 1992
The metabolic fate of infused L-tryptophan in men: possible clinical implications of the accumulation of circulating tryptophan and tryptophan metabolitesG Heuther, G Hajak, A Reimer, et al.
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Treatment of obstructive sleep apnea syndrome by ambulatory, comprehensive, behavior therapy oriented weight reduction (Optifast program)]G Herrendorf, G Hajak, A Rodenbeck, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 5, 1998
Rebound insomnia after hypnotic withdrawal in insomniac outpatientsG Hajak, P Clarenbach, W Fischer, et al.
The Journal of Clinical Psychiatry|July 24, 2001
Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic studyG Hajak, A Rodenbeck, U Voderholzer, et al.
Der Nervenarzt|September 1, 1995
[Chronification of sleep disorders. Results of a representative survey in West Germany]S Simen, G Hajak, G Schlaf, et al.
Pharmacopsychiatry|September 1, 1996
Nocturnal melatonin secretion and sleep after doxepin administration in chronic primary insomniaG Hajak, A Rodenbeck, L Adler, et al.
Psychopharmacology|January 24, 1998
No evidence for a physiological coupling between melatonin and glucocorticoidsG Hajak, A Rodenbeck, H D Ehrenthal, et al.
The European Respiratory Journal|August 9, 2002
Biochemical markers of cerebrovascular injury in sleep apnoea syndromeW Jordan, J Hagedohm, J Wiltfang, et al.
Pageof 14